Alpha interferon administration to infants with congenital rubella.

Three infants with congenital rubella syndrome were given human leukocyte (alpha) interferon at doses of 2 x 10(5) to 7 X 10(5) U/kg per day for 10 days. A transient decrease in pharyngeal virus excretion was observed with treatment. No significant side effects were associated with the administratio...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Arvin, A M, Schmidt, N J, Cantell, K, Merigan, T C
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1982
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC181869/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6176183/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.21.2.259
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!